2018 Annual Meeting | E328 - Role of Placebo in Neuromuscular Clinical Trials and in Management of NM Disorders

Date Friday 04/27/18

Time 08:00 AM - 09:10 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Research)

Director(s) Aziz I. Shaibani, MD, FAAN, Richard J. Barohn, MD, FAAN

Topic(s)

CME Available 0.00 credit

Event Timeline
08:00 AM - 09:10 AM	Speaker	Role of Placebo in Neuromuscular Clinical Trials and in Management of NM Disorders Richard J. Barohn, MD, FAAN, Aziz I. Shaibani, MD, FAAN

Faculty Disclosures
Aziz I. Shaibani, MD, FAAN	Dr. Shaibani has nothing to disclose.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.

��ɫ����